Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at...

Area of Science:

• Oncology
• Molecular Genomics
• Personalized Medicine

Background:

• Non-small cell lung cancer (NSCLC) is a complex disease with diverse molecular profiles.
• Advancements in identifying oncogenic mutations have driven the development of targeted therapies.
• Personalizing treatment based on tumor molecular genomics is a key therapeutic goal.

Purpose of the Study:

• To review approved and emerging targeted therapies for actionable mutations in NSCLC.
• To discuss the current state of molecular testing in community oncology.
• To propose a collaborative framework to enhance personalized NSCLC treatment in community settings.

Main Methods:

• Literature review of approved and investigational targeted therapies for NSCLC.
• Analysis of current molecular testing practices in community oncology.
• Development of a proposed collaborative framework between community and academic oncology sites.

Main Results:

• Several targeted therapies are approved for specific mutations in NSCLC.
• Promising new targets and therapies are under investigation.
• Molecular testing rates and utilization in community settings require improvement.

Conclusions:

• Personalized therapy based on molecular profiling is transforming NSCLC treatment.
• Enhanced molecular testing and collaborative models are crucial for broader implementation of precision oncology in community practice.
• A framework involving increased testing, virtual tumor boards, and integrated health records can optimize personalized NSCLC care.